Skip to content
10-Q

Quarterly Report

IRIS BIOTECHNOLOGIES INC

0001554795-16-000805

← back to feed
Filed
Aug 15, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Aug 15, 2016 20.88M sh
Operating Cash Flow Q2 2016 · Jun 30, 2016 −$122.2K
Operating Cash Flow Q2 2016 · Jun 30, 2015 −$250.41K
Cash And Equivalents Q2 2016 · Jun 30, 2016 $7.64K
Cash And Equivalents Q2 2016 · Dec 31, 2015 $19.84K
Cash And Equivalents Q2 2016 · Jun 30, 2015 $45.15K
Cash And Equivalents Q2 2016 · Dec 31, 2014 $322.93K
Stockholders Equity Q2 2016 · Jun 30, 2016 −$359.4K
Stockholders Equity Q2 2016 · Dec 31, 2015 −$441.5K
Current Liabilities Q2 2016 · Jun 30, 2016 $371.55K
Current Liabilities Q2 2016 · Dec 31, 2015 $468.58K
Total Liabilities Q2 2016 · Jun 30, 2016 $392.55K
Total Liabilities Q2 2016 · Dec 31, 2015 $494.58K
Current Assets Q2 2016 · Jun 30, 2016 $7.64K
Current Assets Q2 2016 · Dec 31, 2015 $23.46K
Total Assets Q2 2016 · Jun 30, 2016 $33.15K
Total Assets Q2 2016 · Dec 31, 2015 $53.08K
Sga Expense Q2 2016 · Jun 30, 2016 $154.05K
Sga Expense Q2 2016 · Jun 30, 2016 $299.64K
Sga Expense Q2 2016 · Jun 30, 2015 $176.41K
Sga Expense Q2 2016 · Jun 30, 2015 $433.63K
Rd Expense Q2 2016 · Jun 30, 2016 $31.93K
Rd Expense Q2 2016 · Jun 30, 2016 $69.48K
Rd Expense Q2 2016 · Jun 30, 2015 $22.75K
Rd Expense Q2 2016 · Jun 30, 2015 $44.36K
Net Income Q2 2016 · Jun 30, 2016 −$188.55K
Net Income Q2 2016 · Jun 30, 2016 −$662.16K
Net Income Q2 2016 · Jun 30, 2015 −$200.83K
Net Income Q2 2016 · Jun 30, 2015 −$481.03K
Operating Income Q2 2016 · Jun 30, 2016 −$188.03K
Operating Income Q2 2016 · Jun 30, 2016 −$373.22K
Operating Income Q2 2016 · Jun 30, 2015 −$200.33K
Operating Income Q2 2016 · Jun 30, 2015 −$479.97K
Capex Q2 2016 · Jun 30, 2015 $27.38K